Faron Pharmaceuticals reports promising outcomes in cancer treatment trials; aiming for FDA approval

Faron Pharmaceuticals Ltd chief executive Dr Markku Jalkanen joined Proactive's Stephen Gunnion with encouraging outcomes ...